ID

23052

Description

Safety and Effectiveness of D-Serine in Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00322023

Lien

https://clinicaltrials.gov/show/NCT00322023

Mots-clés

Versions (1)
  1. 21/06/2017 21/06/2017 -
Téléchargé le

21 juin 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Schizophrenia NCT00322023

Anglais

Eligibility Schizophrenia NCT00322023

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
structured clinical interview for dsm-iii-r diagnosis of schizophrenia or schizoaffective disorder
Description

Schizophrenia | Schizoaffective Disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0036341
UMLS CUI [2]
C0036337
panss 3 factor negative symptom inclusion score greater than 20 prior to study entry
Description

Positive and negative syndrome scale Factor Analysis

Type de données

boolean

Alias
UMLS CUI [1,1]
C0451383
UMLS CUI [1,2]
C0085801
panss total score between 60 and 110
Description

Positive and negative syndrome scale

Type de données

boolean

Alias
UMLS CUI [1]
C0451383
simpson-angus scale total score of 12 or less
Description

Rating scale Parkinsonism

Type de données

boolean

Alias
UMLS CUI [1,1]
C0681889
UMLS CUI [1,2]
C0242422
calgary depression inventory total score of 10 and suicide score less than 2
Description

Depression score | Suicide score

Type de données

boolean

Alias
UMLS CUI [1]
C3483981
UMLS CUI [2]
C0560334
no change in clinical global impressions (cgi) scale score prior to study entry
Description

Clinical Global Impression Questionnaire unchanged

Type de données

boolean

Alias
UMLS CUI [1,1]
C3639708
UMLS CUI [1,2]
C0442739
chlorpromazine (cpz) equivalent of 1500 or less
Description

Chlorpromazine equivalent Dosage

Type de données

boolean

Alias
UMLS CUI [1,1]
C0008286
UMLS CUI [1,2]
C3242703
UMLS CUI [1,3]
C0178602
willing to use an effective form of birth control throughout the study if sexually active
Description

Sexually active Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C0241028
UMLS CUI [1,2]
C0700589
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
high extrapyramidal symptom (eps) levels
Description

Extrapyramidal symptoms High

Type de données

boolean

Alias
UMLS CUI [1,1]
C0234133
UMLS CUI [1,2]
C0205250
began, discontinued, or adjusted psychotropic medication within 2 weeks of study entry
Description

Psychotropic Drugs Started | Psychotropic Drugs Discontinued | Psychotropic Drugs Adjusted

Type de données

boolean

Alias
UMLS CUI [1,1]
C0033978
UMLS CUI [1,2]
C1272689
UMLS CUI [2,1]
C0033978
UMLS CUI [2,2]
C1444662
UMLS CUI [3,1]
C0033978
UMLS CUI [3,2]
C0456081
taking investigational medication within 2 weeks of study entry
Description

Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C0013230
contraindication to study medication
Description

Medical contraindication Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0013230
serious or unstable medical illness
Description

Illness Serious | Illness Unstable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C0221423
UMLS CUI [2,2]
C0443343
pregnant or breastfeeding
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
alcohol or drug abuse within 6 months of study entry
Description

Substance Use Disorders

Type de données

boolean

Alias
UMLS CUI [1]
C0038586
diagnosed with neurodegenerative disease or a seizure disorder
Description

Neurodegenerative Disorders | Epilepsy

Type de données

boolean

Alias
UMLS CUI [1]
C0524851
UMLS CUI [2]
C0014544
history of a kidney impairment
Description

Renal Insufficiency

Type de données

boolean

Alias
UMLS CUI [1]
C1565489
currently taking clozapine
Description

Clozapine

Type de données

boolean

Alias
UMLS CUI [1]
C0009079
currently taking more than two antipsychotic medications
Description

Antipsychotic Agents Quantity

Type de données

boolean

Alias
UMLS CUI [1,1]
C0040615
UMLS CUI [1,2]
C1265611
currently taking stimulants or cholinesterase inhibitors
Description

Stimulant | Cholinesterase Inhibitors

Type de données

boolean

Alias
UMLS CUI [1]
C0304402
UMLS CUI [2]
C0008425
Retour au début de la page

Similar models

Eligibility Schizophrenia NCT00322023

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Schizophrenia | Schizoaffective Disorder
Item
structured clinical interview for dsm-iii-r diagnosis of schizophrenia or schizoaffective disorder
boolean
C0036341 (UMLS CUI [1])
C0036337 (UMLS CUI [2])
Positive and negative syndrome scale Factor Analysis
Item
panss 3 factor negative symptom inclusion score greater than 20 prior to study entry
boolean
C0451383 (UMLS CUI [1,1])
C0085801 (UMLS CUI [1,2])
Positive and negative syndrome scale
Item
panss total score between 60 and 110
boolean
C0451383 (UMLS CUI [1])
Rating scale Parkinsonism
Item
simpson-angus scale total score of 12 or less
boolean
C0681889 (UMLS CUI [1,1])
C0242422 (UMLS CUI [1,2])
Depression score | Suicide score
Item
calgary depression inventory total score of 10 and suicide score less than 2
boolean
C3483981 (UMLS CUI [1])
C0560334 (UMLS CUI [2])
Clinical Global Impression Questionnaire unchanged
Item
no change in clinical global impressions (cgi) scale score prior to study entry
boolean
C3639708 (UMLS CUI [1,1])
C0442739 (UMLS CUI [1,2])
Chlorpromazine equivalent Dosage
Item
chlorpromazine (cpz) equivalent of 1500 or less
boolean
C0008286 (UMLS CUI [1,1])
C3242703 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
Sexually active Contraceptive methods
Item
willing to use an effective form of birth control throughout the study if sexually active
boolean
C0241028 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Extrapyramidal symptoms High
Item
high extrapyramidal symptom (eps) levels
boolean
C0234133 (UMLS CUI [1,1])
C0205250 (UMLS CUI [1,2])
Psychotropic Drugs Started | Psychotropic Drugs Discontinued | Psychotropic Drugs Adjusted
Item
began, discontinued, or adjusted psychotropic medication within 2 weeks of study entry
boolean
C0033978 (UMLS CUI [1,1])
C1272689 (UMLS CUI [1,2])
C0033978 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C0033978 (UMLS CUI [3,1])
C0456081 (UMLS CUI [3,2])
Investigational New Drugs
Item
taking investigational medication within 2 weeks of study entry
boolean
C0013230 (UMLS CUI [1])
Medical contraindication Investigational New Drugs
Item
contraindication to study medication
boolean
C1301624 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Illness Serious | Illness Unstable
Item
serious or unstable medical illness
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0221423 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Substance Use Disorders
Item
alcohol or drug abuse within 6 months of study entry
boolean
C0038586 (UMLS CUI [1])
Neurodegenerative Disorders | Epilepsy
Item
diagnosed with neurodegenerative disease or a seizure disorder
boolean
C0524851 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
Renal Insufficiency
Item
history of a kidney impairment
boolean
C1565489 (UMLS CUI [1])
Clozapine
Item
currently taking clozapine
boolean
C0009079 (UMLS CUI [1])
Antipsychotic Agents Quantity
Item
currently taking more than two antipsychotic medications
boolean
C0040615 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Stimulant | Cholinesterase Inhibitors
Item
currently taking stimulants or cholinesterase inhibitors
boolean
C0304402 (UMLS CUI [1])
C0008425 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial